Trial Profile
Efficacy of neoadjuvant cetuximab for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Cisplatin; Fluorouracil
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 20 Oct 2015 New trial record